Morgan Stanley have just increased their target price to $2.00 and so they obviously feel they have a good offering.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025